image credit- shutterstock
W Health Ventures has launched its $70 million second fund to build and scale generational healthcare companies from scratch in India, serving both domestic and international markets. Fund II doubles down on W Health’s distinctive company creation model through an active, hands-on approach to launching and scaling healthcare companies.
India’s $370 billion healthcare market is undergoing a structural shift. Domestic demand for high-quality and ‘patient-centric’ care is rising, and global interest in healthcare products and services from India is accelerating. Yet building in healthcare remains challenging. The sector is heavily regulated, relationship-driven, clinically complex, and slow to change, making it difficult for start-up founders to break through. W Health overcomes these barriers by embedding startup infrastructure, an entrepreneurial platform team, and strategic capital at the point of incubation in partnership with 2070 Health, India’s first healthcare venture studio.
W Health’s Fund I investments already serve over 25 million patients globally. These include Nivaan (chronic pain), Mylo (parenting), BeatO (diabetes), and BabyMD (paediatrics) in India, along with cross-border companies like Wysa (AI mental health services) and Reveal HealthTech (AI transformation services).
With Fund II, W Health will build 8 to 10 new companies over the next four years, focused on the two proven themes from Fund I. The first is single-specialty care delivery platforms that fill critical clinical ‘white spaces’ in India. The second is AI-enabled B2B healthcare services companies that support US-based healthcare firms by leveraging AI automation and drawing on India’s deep pool of clinical and engineering talent.
W Health has already begun deploying capital from its second fund. EverHope Oncology, a Fund II investment, offers a glimpse of what lies ahead. The company was founded with a bold vision to reinvent cancer care in India by bringing global advancements in oncology to the country. This includes best-in-class clinical protocols, advanced diagnostics, breakthrough therapies, and modern, comfortable treatment spaces outside of hospitals and closer to patients’ homes. Everhope secured a $10 million day-zero investment led by Narayana Health, one of India’s most respected healthcare providers.
